A RISK SCORE BASED ON PREOPERATIVE SERUM METABOLOMIC PROFILES IDENTIFIES PATIENTS WITH EARLY BREAST CANCER AT INCREASED RISK OF RECURRENCE IN A MULTICENTER POPULATION: OUTCOMES BY ADJUVANT ONLINE STRATIFICATION